Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | SMPL LIFE SCIENCES PRIVATE LIMITEDLikely | Evaluation in Progress | 1 | ₹458.40 |
| 2 | Schedule 2 | SHRI VINAYAK PHARMALikely | RA Ended | 1 | ₹24,347.70 |
| 3 | Schedule 3 | SHRI VINAYAK PHARMA | Awarded | 1 | ₹5,264 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
3 Aug 2023, 9:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Nevirapine 200 mg Tab (Q3)
Tab Metoprolol XL 25 mg (Q3)
Apixaban 5 mg Tab (Q3)
5071867
GEM/2023/B/3728977
Two Packet Bid
Nevirapine 200 mg Tab,Tab Metoprolol XL 25 mg,Apixaban 5 mg Tab
30 days
Maharashtra; Pune
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
50%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Nevirapine 200 mg Tab (Q3) | PUNE | 120 | 30 days | |
| Tab Metoprolol XL 25 mg (Q3) | PUNE | 62,430 | 30 days | |
| Apixaban 5 mg Tab (Q3) | PUNE | 2,800 | 30 days |
Exempted
3 Aug 2023
24 Jul 2023
3 Aug 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5071867.pdf
GEM_BID
nevirapine_2023-07-22-12-18-59_f9187d1e85f98b85ccc2638a2d7c528f.pdf
SPECIFICATION
nevirapine_2023-07-22-12-20-51_adae0fed4fec50e6d42656bb10f7a622.pdf
SPECIFICATION
nevirapine_2023-07-22-12-22-38_726c753539ad9836e8c7574076718ce9.pdf
SPECIFICATION
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .